𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis

✍ Scribed by Michihiro Ogasawara; Naoto Tamura; Michiaki Kageyama; Shin Onuma; Makio Kusaoi; Shoko Toyama; Fumio Sekiya; Ran Matsudaira; Masuyuki Nawata; Kurisu Tada; Masakazu Matsushita; Kazuo Kempe; Hirofumi Amano; Shinji Morimoto; Ken Yamaji; Yoshinari Takasaki


Publisher
Springer
Year
2011
Tongue
English
Weight
489 KB
Volume
31
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.